Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/26/2022
Two Large Out-licensing Deals Edge November Deal Values to Over $2.9B ...
12/23/2022
Eisai Initiates BLA Filing for Alzheimer's Drug Lecanemab in China
12/22/2022
Merck and Kelun Ink Exclusive License Pact for Seven Investigational ...
12/22/2022
NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
12/22/2022
NMPA and Chinese Customs Issues the Announcement for Regulation of Imp...
12/22/2022
CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
12/20/2022
Chinese Pharmacopoeia Commission Publishes the Compilation Guidelines ...
12/19/2022
NMPA Hosts BRICS Drug Regulatory Authorities Meeting via Videoconferen...
12/19/2022
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
12/19/2022
GenFleet and Merck Enter into Trial Collaboration to Initiate Study In...
12/16/2022
Recent Executive Moves
12/15/2022
Wuxi Biologics Removed from U.S. Unverified List
12/14/2022
Pfizer and China Meheco Announce Deal to Distribute COVID-19 Drug Paxl...
12/14/2022
Idorsia Out-licenses to Simcere Its Insomnia Drug Daridorexant in Chin...
12/14/2022
China Aims to Lead Next Bio Revolution with Investments in Advanced Bi...
12/13/2022
Biosion Enters Research Collaboration with ImmunoGen to Create Novel A...
12/13/2022
Financing Rebounds for Chinese Drugmakers in November
12/12/2022
IQVIA: Chinese Retail Pharmacy Sales down 3.6% in MAT Q3/2022
12/12/2022
Sinohealth: Drug Sales of Chinese Retail Pharmacy Sector Up 3.8% in Fi...
12/8/2022
Sinopharm Considering Bid to Take China TCM for $4B: Bloomberg
12/8/2022
November Sees Several Approvals for China-developed Drugs (PharmaDJ)
12/6/2022
NHSA Announces Postponement of On-Site Negotiations for the 2022 NRDL
12/6/2022
Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
12/5/2022
Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
12/5/2022
Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
12/2/2022
HanAll's Licensed Partner in China Enters Sublicense Agreement with CS...
12/2/2022
Recent Executive Moves
12/2/2022
China's Challenge in the Drug Services Field (C&EN)
12/1/2022
A Growing Number of Drugmakers in China Are on A Quest to Treat NASH (...
12/1/2022
Eli Lilly Dumps Innovent's PD-1 after FDA Rebuff (FiercePharma)
Page:
33
/
333
Total number of articles:
9989
:
[First]
[<<]
[31]
[32]
[33]
[34]
[35]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit